RAFE PIMCO RAFI ESG U.S. ETF

Expense Ratio
0.29%
Dividend
1.70%
Previous close
$41.67
Est. 12 months change
+17.35%
Projected Price
$48.90

Profitability Metrics

Return on Equity (ROE)
34.14%
Return on Assets (ROA)
8.71%
Return on Invested Capital (ROIC)
22.66%
Weighted Average Cost of Capital (WACC)
7.75%
ROIC - WACC
14.92%
Updated : 2026-04-04 07:35 ET

Valuation Metrics

P/E Ratio
19.63
Forward P/E
15.50
PEG Ratio
2.12
Debt Current Ratio
1.41

Growth & Cash Flow

Gross Margin
49.56%
Operating Margin
19.98%
FCF Margin
18.51%
TTM Revenue Growth
8.83%
Projected 12M EPS Growth
26.68%

Price Change

Price % from 50 SMA
-2.32%
Price % from 200 SMA
2.03%
6 Months
2.18%
1 Year
15.01%
2 Years
19.12%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
AAPL5.15%
JNJ3.91%
MSFT3.80%
MRK2.60%
T2.56%
VZ2.55%
JPM2.52%
UNH2.48%
PG2.09%
C1.97%

ETF Analysis

Fund Overview

PIMCO RAFI ESG U.S. ETF (RAFE) currently reports 278 stock positions (subject to change), placing it in the broad-based range by holdings breadth. The top line-up is AAPL (5.15%), JNJ (3.91%), MSFT (3.80%), with AAPL as the largest single weight at 5.15%. Together, the top three holdings account for 12.86%, which does not represent a dominant share, indicating less concentration in the very top of the book. The overall construction balances concentrated exposure at the top with broader diversification through the rest of the book.

Profitability & Capital Efficiency

Through the lens of capital efficiency, ROIC is 22.66%, WACC is 7.75%, and the economic spread is 14.92%. On balance, the gap between operating returns and funding costs is healthy, pointing to businesses with genuine pricing and reinvestment advantages. Supporting metrics show ROE at 34.14% and ROA at 8.71%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

From a market pricing perspective, trailing P/E of 19.63, forward P/E of 15.50, PEG of 2.12. With trailing and forward P/E closely aligned, the market appears to be pricing the portfolio on the assumption that earnings remain broadly stable near term. On a growth-adjusted basis, valuation appears reasonable relative to expected growth. The portfolio's weighted current ratio of 1.41 suggests near-term liquidity is more constrained than average. The overall valuation picture is one where the market is paying for a specific earnings and growth outcome — and where any deviation from that path would likely pressure multiples.

Margins & Cash Generation

The margin profile breaks down as follows: gross margin sits at 49.56%, operating margin at 19.98%, and free cash flow margin at 18.51%. Gross margins are in good shape, suggesting the holdings maintain pricing discipline at the revenue-to-cost interface. Operating margins are solid, reflecting adequate cost control relative to the revenue base. The portfolio's FCF margin is healthy, indicating solid cash conversion after capital expenditure needs. The mixed margin profile here calls for selectivity — the portfolio's quality of earnings is not uniform across the holding set.

Growth & Forward Outlook

The near-term directional case rests on two inputs: TTM revenue growth of 8.83% pointing to reasonable revenue execution across the underlying holdings. In parallel, analysts project moderate appreciation over the next 12 months based on current consensus targets. The two figures measure different things — one reflects what businesses are actually delivering, the other what the market expects them to deliver. The extent to which these signals converge or diverge will likely be a primary driver of realized returns relative to current expectations. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Strong Buy

Reviewed in aggregate, this is a high-quality profile with few clear structural weaknesses — a combination that historically tends to support above-average long-term outcomes.

This assessment reflects quantitative metrics only and does not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.